Instrument Fundamentals
| Date | Close | Change | Change (%) | Open | High | Low |
|---|
News
Bayer sues J&J over prostate cancer drug ad campaign - Ad Age
What Johnson & Johnson (JNJ)'s Prostate Cancer Drug Lawsuit Means For Shareholders
Promising Medical Stocks To Research - February 24th - Stock Observer
Is Johnson & Johnson Stock Outperforming the Nasdaq?
Johnson & Johnson $JNJ Shares Sold by Miller Investment Management LP
Johnson & Johnson $JNJ Stake Increased by First Financial Bankshares Inc
Chase Investment Counsel Corp Buys New Position in Johnson & Johnson $JNJ
Johnson & Johnson (JNJ) Valuation Check After New Drug Approvals And US$1b Cell Therapy Investment - Simply Wall St News
Rep. Thomas H. Kean, Jr. Sells Off Shares of Johnson & Johnson (NYSE:JNJ) - Stock Observer
Mufg Securities Americas Inc. Purchases 11,619 Shares of Johnson & Johnson $JNJ - Daily Political
A Look At Johnson & Johnson (JNJ) Valuation After New Long Term TREMFYA Ulcerative Colitis Data
Bloomberg Reports Potential Major Asset Sale by Johnson & Johnson (JNJ)
Bayer sues Johnson & Johnson over marketing of prostate cancer drug
Subcutaneous RYBREVANT®▼ (amivantamab) approved by European Commission for every-three-week and every-four-week dosing for patients with advanced EGFR-mutated non-small cell lung cancer
Company Website: http://www.blackstone.com CAMBRIDGE, Mass
Johnson & Johnson $JNJ Shares Sold by LaFleur & Godfrey LLC - Daily Political
Top Medical Stocks To Consider - February 20th - Markets Daily
Controlling chromophore assembly and coupling via carbon nanohoops enables singlet fission at interchromophore distances up to 16 Å
Johnson And Johnson Weighs DePuy Sale As Governance Approach Shifts
Top Healthcare Stocks To Follow Today - February 20th - Stock Observer
Johnson & Johnson: This Dividend King Could Anchor a Millionaire Retirement Portfolio - AOL
Johnson & Johnson $JNJ Shares Acquired by Vestmark Advisory Solutions Inc.
Johnson & Johnson $JNJ Shares Purchased by Westerkirk Capital Inc.
Johnson & Johnson $JNJ Shares Acquired by Lansforsakringar Fondforvaltning AB publ
Johnson & Johnson $JNJ Stake Lifted by Westerkirk Capital Inc. - Stock Observer
Johnson & Johnson $JNJ Shares Purchased by Bleakley Financial Group LLC
Johnson & Johnson (NYSE:JNJ) Stock Price Down 1.9% - Here's Why - Stock Observer
AMJ Financial Wealth Management Buys 5,496 Shares of Johnson & Johnson $JNJ
Sigma Planning Corp Sells 3,399 Shares of Johnson & Johnson $JNJ - Stock Observer
Johnson & Johnson (JNJ) To Go Ex-Dividend on February 24th - Daily Political
FDA Grants Breakthrough Status To Johnson & Johnson's Cancer Drug For Advanced Head and Neck Cancer - AOL
Johnson & Johnson $JNJ Shares Bought by Stevens Capital Management LP
Johnson & Johnson (NYSE:JNJ) Sets New 12-Month High Following Analyst Upgrade - Stock Observer
Jupiter Asset Management Ltd. Decreases Stake in Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Stock Position Trimmed by GSA Capital Partners LLP
Jupiter Asset Management Ltd. Lowers Stake in Johnson & Johnson $JNJ - Stock Observer
Johnson & Johnson (NYSE:JNJ) Trading Down 1.9% - Here's Why
Johnson & Johnson Sees Unusually Large Options Volume (NYSE:JNJ)
Johnson & Johnson $JNJ Shares Sold by Somerville Kurt F - Markets Daily
Johnson & Johnson (NYSE:JNJ) Given New $210.00 Price Target at Rothschild & Co Redburn
Johnson & Johnson Eyes Medtech Divestiture
Kovack Advisors Inc. Has $4.76 Million Holdings in Johnson & Johnson $JNJ
American Express, Deere Drop Board Diversity Criteria as 78% Disclosure Rate Falls
Johnson & Johnson (NYSE:JNJ) Price Target Raised to $210.00 at Rothschild & Co Redburn - Stock Observer
CenterBook Partners LP Reduces Stake in Johnson & Johnson $JNJ
Fiera Capital Corp Reduces Stake in Johnson & Johnson $JNJ
Johnson & Johnson explores US$20 billion sale of orthopedics unit, source says
Johnson & Johnson Plans $20 Billion Sale of Orthopedics Unit Amid Corporate Restructuring, ETHealthworld
J&J to build new cell therapy manufacturing plant in PA - WHYY
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) plus
Best Healthcare Stocks To Add to Your Watchlist - February 19th - Markets Daily
Johnson & Johnson explores $20 billion sale of an orthopedics unit, Bloomberg News reports
Johnson & Johnson invests $1B in Pennsylvania cell therapy facility | Fox Business
Hemenway Trust Co LLC Has $32.66 Million Holdings in Johnson & Johnson $JNJ
5 Dividend-Paying Giants Have Been on Goldman Sachs Conviction List the Longest
L & S Advisors Inc Purchases 32,086 Shares of Johnson & Johnson $JNJ
Prospector Partners LLC Sells 8,788 Shares of Johnson & Johnson $JNJ
Johnson & Johnson $JNJ Shares Bought by Synovus Financial Corp
2,052 Shares in Johnson & Johnson $JNJ Acquired by Redmont Wealth Advisors LLC - Markets Daily
NewEdge Wealth LLC Buys 7,299 Shares of Johnson & Johnson $JNJ
$18.67 Billion Walk-in Refrigerators Market Opportunity Assessment 2026-2030 & 2035: Panasonic Holdings, Johnson Controls, Blue Star Dominate
Johnson & Johnson (NYSE:JNJ) Passed Our Checks, And It's About To Pay A US$1.30 Dividend
Johnson & Johnson to invest $1 billion in new Pennsylvania plant amid US manufacturing push
Johnson & Johnson $JNJ Stock Position Cut by Burling Wealth Partners LLC - Stock Observer
Redmont Wealth Advisors LLC Purchases New Position in Johnson & Johnson $JNJ - Stock Observer
Cumberland Partners Ltd Acquires 56,015 Shares of Johnson & Johnson $JNJ - Daily Political
NewEdge Wealth LLC Acquires 7,299 Shares of Johnson & Johnson $JNJ - Daily Political
Johnson & Johnson $JNJ Shares Sold by Comgest Global Investors S.A.S. - Daily Political
Johnson & Johnson (NYSE:JNJ) EVP Sells $1,508,287.83 in Stock
Johnson & Johnson announces $1bn cell therapy manufacturing facility in Pennsylvania - The Manufacturer
Johnson & Johnson to Invest Over $1 Billion in New Pennsylvania Plant to Boost U.S. Manufacturing, ETPharma
Persistence of coral reef structures into the twenty-first century
Bispecific T cell engagers for treatment-refractory autoimmune connective tissue diseases
Predicting onset of symptomatic Alzheimerʼs disease with plasma p-tau217 clocks
Johnson & Johnson expands US footprint with more than $1 B investment in next gen cell therapy manufacturing facility
Johnson & Johnson (NYSE:JNJ) EVP Timothy Schmid Sells 22,623 Shares - Stock Observer
Johnson & Johnson class action: Mesothelioma, ovarian cancer links spark Victorian Supreme Court response
Johnson & Johnson invests $1B to build manufacturing facility in Montgomery County, Pa. - CBS Philadelphia
Johnson & Johnson to Invest More Than $1 Billion in Pennsylvania Cell Therapy Factory | Morningstar
Advanced manufacturing site will utilize cutting‑edge cell t
J&J to invest $1 billion in new Pennsylvania plant amid US manufacturing push
Verizon vs Johnson & Johnson: Which Dividend Hike Winner Is the Better Buy? - 24/7 Wall St.
Verizon vs Johnson & Johnson: Which Dividend Hike Winner Is the Better Buy? - AOL
J&J's Rybrevant Faspro Granted FDA Breakthrough Therapy Status For Head And Neck Cancer
Ingalls & Snyder LLC Has $15.03 Million Stock Holdings in Johnson & Johnson $JNJ
RYBREVANT FASPRO™ (amivantamab and hyaluronidase-lpuj) receives U.S. FDA Breakthrough Therapy Designation for patients with advanced head and neck cancer | Morningstar
Is Kenvue (KVUE) Attractively Priced After Spin Off From Johnson & Johnson?
BOK Financial Private Wealth Inc. Lowers Holdings in Johnson & Johnson $JNJ
Advisors Capital Management LLC Grows Position in Johnson & Johnson $JNJ
Fact Check: False claim that Epstein is alive in Colorado misrepresents 2021 emails about different man - Yahoo News Canada
First National Bank of Omaha Purchases Shares of 40,501 Johnson & Johnson $JNJ
Drucker Wealth 3.0 LLC Purchases 11,274 Shares of Johnson & Johnson $JNJ
JnJ News
NVIDIA (NVDA) Stock Price & Overview 2026: What is Nvidia stock prediction?
Novo Nordisk (NVO) stock analysis: Novo shares drop 16%, what’s next for NVO?
Commodity market today: gold (XAU/USD) and sliver dropped, what’s next?
Crude oil forecast today: Are WTI and Brent expected to rise in 2026?
Dividend Stocks and Investing: What are the most popular dividend stocks in 2026?
Bitcoin (BTCUSD) is seeing a modest rise: Is BTC about to reverse and head lower?
